Compare Bundamedik Tbk (BMHS) vs Trimegah Karya Pratama Tbk. (UVCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Trimegah Karya Pratama Tbk. — how do they compare? Bundamedik Tbk trades at Rp189 (market cap 1.62T, 203.2K 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp145 (market cap 292.02B, 20.12M 24h volume). The key difference: Bundamedik Tbk is far larger — about 5.5× Trimegah Karya Pratama Tbk.'s market cap, and Trimegah Karya Pratama Tbk. is more actively traded (20.12M versus 203.2K). Which is the better fit depends on your goals.
| BMHS | UVCR | |
|---|---|---|
Market Cap | 1.62T | 292.02B |
Volume | 203.2K | 20.12M |
Lot | 2.03K | 201.17K |
Turnover | 38.36M | 2.9B |
Average Price | 188.77 | 144.04 |
Value | 38.36M | 2.9B |
Indicative Equilibrium Price | 190 | 146 |
Indicative Equilibrium Volume | 52 | 117.3K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →
